VV
CVS icon

Verity & Verity’s CVS Health CVS Stock Holding History

Verity & Verity’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-66,540
Closed -$4.94M – 92
2019
Q4 		$4.94M Sell
66,540
-30,081
-31% -$2.11M 0.96% 43
2019
Q3 		$5.88M Sell
96,621
-27,435
-22% -$1.63M 1.24% 33
2019
Q2 		$6.76M Sell
124,056
-427
-0.3% -$23K 1.47% 28
2019
Q1 		$6.71M Buy
124,483
+4,312
+4% +$266K 1.54% 23
2018
Q4 		$7.87M Buy
120,171
+2,424
+2% +$181K 2.11% 14
2018
Q3 		$9.27M Buy
117,747
+3,233
+3% +$231K 2.23% 13
2018
Q2 		$7.37M Buy
114,514
+16,193
+16% +$1.07M 1.91% 18
2018
Q1 		$6.12M Buy
98,321
+4,959
+5% +$356K 1.65% 24
2017
Q4 		$6.77M Buy
93,362
+5,247
+6% +$381K 1.82% 23
2017
Q3 		$7.17M Buy
88,115
+22,953
+35% +$1.82M 2.09% 17
2017
Q2 		$5.24M Buy
65,162
+52,934
+433% +$4.18M 1.61% 30
2017
Q1 		$960K Buy
+12,228
New +$976K 0.3% 68

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Verity & Verity's CVS Position: Q1 2020 in Review

Verity & Verity sold out of CVS Health (CVS) in Q1 2020, closing a stake of 66,540 shares — an estimated $4.94M sold.

Verity & Verity first reported a position in CVS in Q1 2017 and held it in 12 quarters. The position peaked at $9.27M in Q3 2018. 1,817 funds tracked by Wall St. Rank hold CVS as of Q1 2020.

  • Verity & Verity reported no remaining CVS Health position as of Q1 2020 after selling out during the quarter.
  • Verity & Verity sold 66,540 CVS Health shares in Q1 2020, an estimated $4.94M.
  • Verity & Verity first reported a position in CVS Health in Q1 2017 and held it in 12 quarters.
  • Verity & Verity's CVS Health position peaked at $9.27M in Q3 2018.
  • 1,817 funds tracked by Wall St. Rank held CVS Health as of Q1 2020.

Based on Verity & Verity's 13F filing for Q1 2020, filed 9 Apr 2020.